Journal Article

954PProspective cohort study of bevacizumab plus standard platinum based chemotherapy as front-line treatment for advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer: Japanese Gynecologic Oncology Group study (JGOG3022)

K. Kato, S. Komiyama, N. Takeshima, H. Takano, A. Inoue, A. Hongo, M. Asai-Sato, A. Arakawa, K. Kubushiro, S. Kamiura and T. Sugiyama

in Annals of Oncology

Published on behalf of European Society for Medical Oncology

Volume 28, issue suppl_5 Published in print September 2017 | ISSN: 0923-7534
Published online September 2017 | e-ISSN: 1569-8041 | DOI: http://dx.doi.org/10.1093/annonc/mdx372.025
954PProspective cohort study of bevacizumab plus standard platinum based chemotherapy as front-line treatment for advanced epithelial ovarian cancer, fallopian tube cancer, or primary peritoneal cancer: Japanese Gynecologic Oncology Group study (JGOG3022)

Show Summary Details

Journal Article.  348 words. 

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.